Menu
  • Welcome
  • Resources
  • Webinars
  • News
  • Stats
  • Forums
  • Team
  • Contact
  • My Account
  • FR
  • Welcome
  • Resources
  • Webinars
  • News
  • Stats
  • Forums
  • Team
  • Contact
  • My Account
  • FR
home/Knowledge Base/Intensive Care

Predicting prognosis with Troponin I levels?

131 views 2 04/04/2020 Belinda Jiao

  1. Cardiac troponin I (cTnI) concentrations are greatly increased in patients with severe infections.
  2. Standard measurement of cTnI without suspicion of myocardial injury should be avoided

 

This data comes from a meta-analysis encompassing four studies from China in which cardiac troponin I values in COVID-19 patients were reported as well as disease severity. Of the 341 patients included in the meta-analysis, 123 (36%) had severe infections, defined differently according to study: ICU admission in two studies, onset of ARDS in one, and death in one.

cTnI values were taken during disease progression, thus the main question of predicting prognosis was not answered in this study. Standardized measurement of cTnI without suspicion of myocardial injury might lead to downstream testing.

Sources:

G. Lippi, C.J. Lavie and F. Sanchis-Gomar (March 10, 2020). Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis, Progress in Cardiovascular Diseases, https://doi.org/10.1016/j.pcad.2020.03.001

Meta-Analysis on Troponin I in Patients With Coronavirus (March 24, 2020). Retrieved from https://www.acc.org/latest-in-cardiology/journal-scans/2020/03/24/16/01/cardiac-troponin-i-in-patients-with-coronavirus

Tags:prognosisTroponinSevere diseaseAcute cardiac injuryprogn

Was this helpful?

2 Yes  No
Related Articles
  • Treatment simulation for Health Care Providers: Managing Suspected and Confirmed cases
  • Potential Effect of Complement Pathways in Thrombotic Microvascular Injury
  • Managing Patients With Long QT Syndrome
  • Is Obesity a Risk Factor for Severity?
  • Ventilation phenotypes specific considerations
  • Coagulopathy: What We Know So Far
Intensive Care
  • Predicting prognosis with Troponin I levels?
  • Treatment simulation for Health Care Providers: Managing Suspected and Confirmed cases
  • Potential Effect of Complement Pathways in Thrombotic Microvascular Injury
  • Is Obesity a Risk Factor for Severity?
  • Ventilation phenotypes specific considerations
  • Coagulopathy: What We Know So Far
View All 29  
Popular Articles
  • Acute Acro-Ischemic Lesions in Children
  • Insights About Reinfection and Immunization
  • What Is the Efficacy of Masks in Preventing Transmission?
  • Rationale of Old Antimalarial Drugs Against New Pandemic
  • Acral Lesions: What We Know
Specialties
  • Endocrinology
  • Anesthesiology
  • Cardiology
  • Dental Surgery
  • Dermatology
  • Emergency Medicine
  • ENT
  • Geriatrics and Palliative Care
  • Gastroenterology
  • Hematology
  • Infectious Diseases
  • Intensive Care
  • Neurology
  • OB-GYN
  • Oncology
  • Ophthalmology
  • Pediatrics
  • Pharmacology
  • Preventive Medicine
  • Protection of Healthcare Workers
  • Psychiatry
  • Public health
  • Other Internal Medicine Specialties
  • Radiology
  • Respirology
  • Stages of COVID-19 Infection
    • Presumption & Prevention
    • Screening & Diagnosis
    • Mild Infection
    • Moderate Infection
    • Severe Infection
    • Outcomes
  • Surgery
About How I Treat COVID-19

Our website is dedicated to helping healthcare professionals find accurate and up-to-date information about the best ways to manage and treat patients affected by the COVID-19 outbreak.

Navigation
  • Resources
  • News
  • Webinars
  • Forum
Useful Links
  • COVID-19 Protocols
  • Health Canada
  • WHO
  • CDC
Practice

  • Privacy Policy
  • Terms & Conditions
  • How I Treat Covid-19 © 2020 Made with ♥ by Mondien